Better Therapeutics, Inc. (BTTX)

Trade BTTX now with
12/8/2022 7:12:58 AM Better Therapeutics Completes Exploratory Trial For Fatty Liver Disease And Announces Positive Results
10/4/2022 7:38:22 AM Better Therapeutics Piblishes Positive 90 Day Results From Pivotal Trial For BT-001 For Type 2 Diabetes
9/22/2022 7:37:36 AM Better Therapeutics Submits De Novo Request To FDA For BT-001 Prescription Digital Therapy For Type 2 Diabetes
8/11/2022 7:45:45 AM Better Therapeutics, Inc. Q2 Net Loss/shr $0.42 Vs. Loss/shr $0.84 Last Year
6/7/2022 7:33:28 AM Better Therapeutics Names Frank Karbe CEO Starting July 5th, 2022
5/13/2022 7:14:27 AM Better Therapeutics Q1 Loss Per Share $0.41 Vs Loss $0.54 Last Year
4/6/2022 7:33:39 AM Better Therapeutics Reports Updates For Ongoing Studies Of Digital Therapeutics Approach For Cardiometabolic Diseases
3/28/2022 7:29:42 AM Better Therapeutics FY Loss Attributable To Shareholders $13.9 Mln Or $0.71/Shr Vs Loss $2.1 Mln Or $0.20/Shr Last Year
3/15/2022 7:14:45 AM Better Therapeutics Announces Positive Primary Data From Clinical Trial Of BT-001 For Uncontrolled Type 2 Diabetes